Mary-Jane Burkett
Profile
Mary-Jane E.
Burkett is currently the Chief Financial Officer & Vice President at Nuvo Pharmaceuticals, Inc. She started this position in 2016.
Prior to her current role, she worked as a Controller at Crescita Therapeutics, Inc. Ms. Burkett completed her undergraduate degree at Richard Ivey School of Business.
Former positions of Mary-Jane Burkett
| Companies | Position | End |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
| NUVO PHARMACEUTICALS INC. | Director of Finance/CFO | - |
Training of Mary-Jane Burkett
| Richard Ivey School of Business | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Mary-Jane Burkett
